Slicing through the challenge of maintaining Pneumocystis in the laboratory

mBio. 2024 Mar 13;15(3):e0327723. doi: 10.1128/mbio.03277-23. Epub 2024 Feb 12.

Abstract

Pneumocystis jirovecii is a major fungal pathogen of humans that causes life-threatening lung infections in immunocompromised individuals. Despite its huge global impact upon human health, our understanding of the pathobiology of this deadly fungus remains extremely limited, largely because it is not yet possible to cultivate Pneumocystis in vitro, independently of the host. However, a recent paper by Munyonho et al. offers a major step forward (F. T. Munyonho, R. D. Clark, D. Lin, M. S. Khatun, et al., 2023, mBio 15:e01464-23, https://doi.org/10.1128/mbio.01464-23). They show that it is possible to maintain both the trophozoite and cyst forms of the mouse pathogen, Pneumocystis murina, in precision-cut lung slices for several weeks. Furthermore, they demonstrate that this offers the exciting opportunity to examine potential virulence factors such as possible biofilm formation as well as antifungal drug responses in the lung.

Keywords: Pneumocystis; fungal pathogenicity; medical mycology; precision-cut lung slices.

Publication types

  • Comment

MeSH terms

  • Animals
  • Antifungal Agents
  • Humans
  • Lung
  • Mice
  • Pneumocystis*
  • Pneumonia, Pneumocystis*

Substances

  • Antifungal Agents

Supplementary concepts

  • Pneumocystis murina